Children and adolescents

PATH worked to fight malnutrition, prevent cervical cancer, and advance a promising malaria vaccine candidate. Learn about four of our key 2011 achievements below.

Malaria vaccine candidate hailed as major medical breakthrough

Innovation: A vaccine candidate advanced by the PATH Malaria Vaccine Initiative with partner GlaxoSmithKline Biologicals could offer new hope for the control of malaria in Africa. If all goes well, the World Health Organization has indicated that a policy recommendation for RTS,S is possible as early as 2015.

Impact: First results of a phase 3 trial under way in seven African countries showed that, in the year following vaccination, RTS,S cut the number of malaria episodes by about half in the 5- to 17-month-old children who received it. Time magazine called this achievement one of the top ten medical breakthroughs of 2011.

Improving nutrition

Working across 16 countries, PATH led groundbreaking efforts to improve nutrition among mothers-to-be and young children. With our partners, we promoted evidence-based nutrition interventions, enhanced national nutrition policies, created tools to strengthen nutrition programs, and trained more than 2,300 health care providers in 2011 to support caregivers. Innovation Funding

Combating cervical cancer

PATH-led demonstration projects on vaccination strategies against the primary cause of cervical cancer paved the way for Peru to launch a national vaccination campaign in 2011. PATH’s work contributed to the GAVI Alliance’s decision to subsidize human papillomavirus vaccines for the world’s poorest countries starting in 2012. Innovation Funding

Fighting malnutrition

PATH and our partners announced a new effort to fight malnutrition in Brazil by reaching 10 million low-income consumers over the next three years with fortified rice made with PATH’s Ultra Rice® fortification technology. Innovation Funding

Learn more

Ultra Rice is a registered US trademark of Bon Dente International, Inc.